Teleflex to Focus on Advanced Interventional Radiology Products at CIRSE
September 12 2014 - 7:00AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, will
showcase its Arrow® brand interventional radiology portfolio at the
Annual Meeting of the Cardiovascular and Interventional
Radiological Society of Europe (CIRSE) to be held in Glasgow,
Scotland on September 13-17, 2014.
During the event, the Company will highlight both the Arrow®
GPSCath™ Balloon Dilatation Catheter featuring innovative
VisioValve™ technology over a 0.014 guidewire - now for BTK (below
the knee), and the Arrow OnControl® Powered Bone Access System. In
addition, the Company will also present highly kink-resistant
sheath introducers, dialysis access products and angiographic
diagnostic catheters.
The GPSCath™ Catheter is a specialty two-in-one device that is
intended for BTK allowing the physician to conduct angioplasty and
inject fluid [targeted angiogram specifically at lesion site] while
maintaining catheter and guidewire position. Below-the-knee
interventions can be complex undertakings, requiring multiple
devices, numerous procedural steps and significant procedural time.
Arrow now offers a solution by combining multiple required features
into one device.
The Arrow OnControl Powered Bone Access System offers the
ability to effectively, safely and rapidly obtain superior bone
samples. Our bone lesion biopsy needle is designed specifically for
multiple bone biopsies from a single cortical penetration. Using
Teleflex’s patented technology, the Arrow OnControl Powered Bone
Access System provides interventional radiologists a faster, more
reliable solution for accessing dense and hard-to-reach bone
lesions.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Wayne, PA, Teleflex employs approximately 11,500
people worldwide and serves healthcare providers in more than 150
countries. Additional information about Teleflex can be obtained
from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, Arrow, GPSCath, VisioValve and OnControl are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates. © 2014 Teleflex Incorporated. All rights reserved.
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor
Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.comorMartina
Teichmann-ZindlerDirector Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.comwww.teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024